Melissa Larson

8PUBLICATIONS

93CO-AUTHORS

Disease surveillanceMolecular targetsLiquid biopsiesReproductionHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 24, 2026

No association of prior administration of selected vaccines with lymphoma prognosis.

|Jan 14, 2026

Dual FAK and EPHA2 targeting by brigatinib tackles PARP inhibitor adaptive survival response in high-grade serous ovarian cancer.

Julie R Duffield, Xiaonan Hou, Benjamin W Wilson

|Dec 02, 2025

FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.

Matthew J Maurer, Vit K Prochazka, Tarec Christoffer El-Galaly

|Nov 03, 2025

Occurrence and predictors of patient reported fertility discussions in non-Hodgkin lymphoma patients: utilizing the lymphoma epidemiology of outcomes (LEO) cohort study.

Nadia Toumeh, Melissa Larson, Brianna Negaard

|Mar 06, 2025

Evaluation of Etiologic Heterogeneity for Risk of Diffuse Large B-Cell Lymphoma Subtype Defined by the Cell of Origin.

Geffen Kleinstern, Dennis P Robinson, Lisa M Rimsza

|Feb 07, 2025

Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study.

Samuel Yamshon, Jean L Koff, Melissa C Larson

Pageof 2

Frequent Collaborators

Matthew Maurer

Thomas M Habermann

James R Cerhan

Andrew L Feldman

Dai Chihara

Yucai Wang

Grzegorz S Nowakowski

3 joint publications

Izidore S Lossos

3 joint publications

Brad S Kahl

3 joint publications

Brian K Link

Frequent Collaborators

Matthew Maurer

Thomas M Habermann

James R Cerhan

Andrew L Feldman